Skip to content
Home/Companies/Pharma/Quotient Sciences
QS

Quotient Sciences

Pharma·UK·Exited 2019·Held 4yr

Quotient Sciences is a pharma company, headquartered in UK.

Entry
2015
Hold
4yr
Exit
2019
Est. EV
–

Who owns Quotient Sciences?

Quotient Sciences was owned by GHO Capital through GHO Capital Fund I LP (2015 vintage) from 2015 to 2019, exited via Secondary.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

GHO Capital
Investor
GHO Capital
GHO Capital Fund I LP · 2015 · Buyout

Key facts

HQUK
SectorPharma
StatusAcquired
Exit Type
Secondary
Buyer
MOIC
–
Exit Year
2019

More from GHO Capital Fund I LP

Other portfolio companies in the same fund.

BioAgilytix
Exited 2021
BiotechUnited States· 2018
to
Caprion Biosciences
Exited 2019
BiotechCanada· 2016
to
VISUfarma
Exited 2026
PharmaUK· 2016
to
DNA Diagnostics Center
Exited 2021
HealthcareUnited States· 2015
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Delpharm
Active
SocadifFrance
Laboratoires Delbert
Active
SocadifFrance
IRAB
Active
ARCHIMEDSpain· 2026
Biogaran
Active
BC PartnersFrance· 2025
Dec Group
Active
capitonSwitzerland· 2025
Essential Pharma
Active
Penta CapitalUK· 2025
Data refreshed weekly · Sourced from public filings